AREDS 5-step Simplified Severity Scale for Macular Degeneration Classification- a Novel Design Dr Ishan Kataria3 March 2023 8:00 PM ISTAge-related macular degeneration (AMD) is responsible for approximately 9% of global blindness and is the leading cause of visual loss in developed...
FDA approves Syfovre as first treatment for geographic atrophy Dr. Kamal Kant Kohli21 Feb 2023 8:00 PM ISTUSA: Pegcetacoplan injection (Syfovre) has received approval from the US Food and Drug Administration (FDA) as the first treatment for geographic...
Novel gene therapy shows promise for treating multiple eye diseases Dr. Kamal Kant Kohli20 Feb 2023 8:00 PM ISTResearchers from Trinity College Dublin have discovered that a potential new gene therapeutic approach may also be effective in treating patients...
Two separate eye diseases may contribute to early age-related macular degeneration Dr. Kamal Kant Kohli26 Jan 2023 8:00 PM ISTTwo separate eye diseases may contribute to age-related macular degeneration (AMD), a leading cause of blindness in the United States, according to a...
Obesity may be number one non-genetic risk factor for developing AMD, finds study Dr. Kamal Kant Kohli13 Jan 2023 8:00 PM ISTResearchers at Hopital Maisonneuve-Rosement in Montreal have found in a new study published in the prestigious journal Science that obesity or...
Age-related macular degeneration confers greater risk of COVID-19 infection and mortality Dr. Kamal Kant Kohli9 Jan 2023 9:00 AM ISTUSA: Findings from a new study, published in Journal of Clinical Medicine, adds to the body of evidence that patients with age-related macular...
AMD associated with heart damage from HF, heart attacks or advanced heart valve disease Dr. Kamal Kant Kohli21 Nov 2022 8:00 PM ISTResearchers at New York Eye and Ear Infirmary of Mount Sinai have found in a new study that Patients with a specific form of age-related macular...
Intravitreal pegcetacoplan shows positive results in geographic atrophy in phase 3 trials Dr. Kamal Kant Kohli28 Aug 2022 8:00 PM ISTThere was an increased effect of intravitreal pegcetacoplan in geographic atrophy (GA) secondary to age-related macular degeneration (AMD) according...
Novel oral, multi-kinase inhibitor therapy effective in exudative AMD: APEX trial Dr Ishan Kataria26 Jun 2021 8:00 AM ISTAge-related macular degeneration (AMD) is one of the most common causes of visual loss, projected to affect nearly 200 million people worldwide....
Novel eyedrop is promising wet AMD treatment Hina Zahid7 May 2021 9:00 AM ISTRockville, Md. - New research has resulted in a new potential therapeutic option for vascular endothelial growth factor (VEGF) after being...
Exposure to Air pollution May Lead to Permanent Vision Loss: study MD Bureau28 Feb 2021 10:55 PM ISTAir pollution is a global and major public health problem. The Global Burden of Diseases, Injuries, and Risk factors Study reported that air pollution...
Low Dose of Metformin May Prevent Development of AMD: JAMA Study MD Bureau30 Jan 2021 11:15 AM ISTMetformin, classified as biguanide, is the first - line and most widely used medication for patients with type 2 diabetes. In addition to its main...
